Proteolytic Enzyme Therapy in Evidence-Based Complementary Oncology

[Guest guest]

Dear all,

There is no need to get scared about enzymatic therapies in cancers.They do

help in getting tumour response to treatments by disintegrating fibrinoprotein

covering of tumors and make easy targets for the immune system to kill cancer

cells by natural autophagy means.

Also there are studies to show proteolytic enzymes mitigate tumor-induced and

therapy-induced side effects.(Please note the word 'antimetastatic'in the study.

-----------

Josef Beuth, MD

Institute of Naturopathy, University of Cologne, Cologne, Germany,

hans.beuth

 

Systemic enzyme therapy was recently subjected to experimental investigations

and to rigorous clinical studies in cancer patients. The designs of the relevant

clinical cohort studies followed the guidelines of Good Epidemiological Practice

and represent level IIB in evidence-based medicine (EBM). Scientifically sound

experimental in vitro and in vivo investigations are far advanced and document

promising immunological, anti-inflammatory, anti-infectious, and

'antitumor/antimetastatic activities'of proteolytic enzyme mixtures (containing

trypsin, chymotrypsin, and papain) or bromelain. EBM level II clinical studies,

which are accepted by the European Union to show safety and efficacy of medical

treatments, were performed to evaluate the benefit of complementary systemic

enzyme therapy in cancer patients suffering from breast and colorectal cancers

and plasmacytoma. These studies demonstrated that systemic enzyme therapy

significantly decreased

tumor-induced and therapy-induced side effects and complaints such as nausea,

gastrointestinal complaints, fatigue, weight loss, and restlessness and

obviously stabilized the quality of life. For plasmacytoma patients,

complementary systemic enzyme therapy was shown to increase the response rates,

the duration of remissions, and the overall survival times. These promising data

resulted in an " orphan drug status " designation for a systemic enzyme product,

which should motivate further studies on this complementary treatment

--------------

So go ahead with your proteolytic enzymes thearpy.

Dr.Kumar